Gene · 3549
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hedgehog Signal Defect Leading to Familial Exudative Vitreoretinopathy-Like Disease and Gastrointestinal Malformation. | Turk J Ophthalmol | 2022 | 35770050 | PubTator, text mining | PubMed |
| Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo. | J Transl Med | 2022 | 35752861 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. | Genes (Basel) | 2022 | 35741711 | PubTator, text mining | PubMed |
| Hedgehog Morphogens Act as Growth Factors Critical to Pre- and Postnatal Cardiac Development and Maturation: How Primary Cilia Mediate Their Signal Transduction. | Cells | 2022 | 35741008 | PubTator, text mining | PubMed |
| Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease. | Biomolecules | 2022 | 35740906 | PubTator, text mining | PubMed |
| The Level of Histone Deacetylase 4 is Associated with Aging Cartilage Degeneration and Chondrocyte Hypertrophy. | J Inflamm Res | 2022 | 35734099 | PubTator, text mining | PubMed |
| Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications. | Front Immunol | 2022 | 35720360 | PubTator, text mining | PubMed |
| MicroRNA-365a/b-3p as a Potential Biomarker for Hypertrophic Scars. | Int J Mol Sci | 2022 | 35682793 | PubTator, text mining | PubMed |
| The Emerging Role of Cell Transdifferentiation in Skeletal Development and Diseases. | Int J Mol Sci | 2022 | 35682655 | PubTator, text mining | PubMed |
| Mechanisms during Osteogenic Differentiation in Human Dental Follicle Cells. | Int J Mol Sci | 2022 | 35682637 | PubTator, text mining | PubMed |
| Hedgehog Signaling: Linking Embryonic Lung Development and Asthmatic Airway Remodeling. | Cells | 2022 | 35681469 | PubTator, text mining | PubMed |
| Progesterone Signaling in Endometrial Epithelial Organoids. | Cells | 2022 | 35681455 | PubTator, text mining | PubMed |
| Case Report: Brachydactyly Type A1 Induced by a Novel Variant of in-Frame Insertion in the IHH Gene. | Front Genet | 2022 | 35669189 | PubTator, text mining | PubMed |
| Stem Cell-Laden Hydrogel-Based 3D Bioprinting for Bone and Cartilage Tissue Engineering. | Front Bioeng Biotechnol | 2022 | 35656197 | PubTator, text mining | PubMed |
| Study on the Mechanism of Sancao Tiaowei Decoction in the Treatment of MNNG-Induced Precancerous Lesions of Gastric Carcinoma Through Hedgehog Signaling Pathway. | Front Oncol | 2022 | 35646631 | PubTator, text mining | PubMed |
| Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy. | Int J Biol Sci | 2022 | 35637973 | PubTator, text mining | PubMed |
| Cell-based therapies for rheumatoid arthritis: opportunities and challenges. | Ther Adv Musculoskelet Dis | 2022 | 35634355 | PubTator, text mining | PubMed |
| Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). | Pharmaceuticals (Basel) | 2022 | 35631368 | PubTator, text mining | PubMed |
| The Role of Matrix-Bound Extracellular Vesicles in the Regulation of Endochondral Bone Formation. | Cells | 2022 | 35626656 | PubTator, text mining | PubMed |
| Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway. | Int J Oncol | 2022 | 35621145 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3549/papers?page=27